Natalizumab for multiple sclerosis
32 results
1 - 32
Natalizumab for relapsing remitting multiple sclerosis 
Natalizumab for relapsing remitting multiple sclerosis- Natalizumab for multiple sclerosis
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
- Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta‐analysis
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis
- Rituximab for people with multiple sclerosis
- Sodium channel blockers for neuroprotection in multiple sclerosis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Azathioprine for people with multiple sclerosis
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Teriflunomide for multiple sclerosis
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
- Multiple sclerosis (MS)